Download

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

Error loading player: No playable sources found
01:00

For the first time in nearly 20 years, U.S. regulators have approved a new treatment for Alzheimer's disease. An advisory committee said there isn't enough evidence to show it works, and it will carry a hefty price tag of $56,000 a year. Dr Jeffrey Burns, the co-director of the Alzheimer's Disease Center at the University of Kansas, shared his insights. Watch the video for more on Alzheimer's and the new treatment, Aduhelm.

MORE FROM CGTN
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Video

09:27, 28-Feb-2025

{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Video

07:58, 28-Feb-2025

{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Video

07:16, 28-Feb-2025

{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Video

07:16, 28-Feb-2025

TOP NEWS
Xi chairs CPC leadership meeting to discuss draft gov't work report
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Politics

06:57, 28-Feb-2025

{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Video

00:00, 28-Feb-2025

Trump dismisses Starmer's call for U.S. military guarantees in Ukraine
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

North America

02:36, 28-Feb-2025

Search Trends